Literature DB >> 12689669

A decade of tyrosine kinases: from gene discovery to therapeutics.

Rolf J Craven1, Harry Lightfoot, William G Cance.   

Abstract

Tyrosine kinases are key regulators of breast cancer cell survival and proliferation. Ten years ago, we conducted a screen for protein kinases expressed in primary human breast tumors and cultured cancer cells. Here, we review the progress from the last ten years in understanding the functions of these kinases with a focus on breast cancer. Three themes emerge: (1). tyrosine kinases regulate proliferation through the MAP Kinase pathway, (2). tyrosine kinases regulate cellular survival through the PI3 Kinase-Akt pathway, and (3). the cell cycle is regulated through a complex series of serine-threonine kinases. Our improved understanding of these signaling cascades has led to novel strategies for therapeutic intervention in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12689669     DOI: 10.1016/s0960-7404(03)00004-5

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  17 in total

1.  TGF-beta1 modulates focal adhesion kinase expression in rat intestinal epithelial IEC-6 cells via stimulatory and inhibitory Smad binding elements.

Authors:  Mary F Walsh; Dinakar R Ampasala; Arun K Rishi; Marc D Basson
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 2.  Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.

Authors:  Woody Han; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

3.  Cytotoxicity of targeted HER2-specific phototoxins based on flavoprotein miniSOG is determined by the rate of their internalization.

Authors:  O N Shilova; G M Proshkina; A V Ryabova; S M Deyev; R V Petrov
Journal:  Dokl Biochem Biophys       Date:  2017-09-02       Impact factor: 0.788

4.  Inhibitory effects of tea polyphenols by targeting cyclooxygenase-2 through regulation of nuclear factor kappa B, Akt and p53 in rat mammary tumors.

Authors:  Preeti Roy; Jasmine George; Smita Srivastava; Shilpa Tyagi; Yogeshwer Shukla
Journal:  Invest New Drugs       Date:  2009-11-20       Impact factor: 3.850

5.  NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts.

Authors:  Karuppaiyah Selvendiran; Anna Bratasz; Liyue Tong; Louis J Ignarro; Periannan Kuppusamy
Journal:  Cell Cycle       Date:  2007-09-28       Impact factor: 4.534

6.  Krüppel-like factor 8 (KLF8) is expressed in gliomas of different WHO grades and is essential for tumor cell proliferation.

Authors:  Oliver Schnell; Alexander Romagna; Irene Jaehnert; Valerie Albrecht; Sabina Eigenbrod; Kathrin Juerchott; Hans Kretzschmar; Jörg-Christian Tonn; Christian Schichor
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

7.  Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours.

Authors:  Jill E Kucab; Cathy Lee; Ching-Shih Chen; Jiuxiang Zhu; C Blake Gilks; Maggie Cheang; David Huntsman; Erika Yorida; Joanne Emerman; Michael Pollak; Sandra E Dunn
Journal:  Breast Cancer Res       Date:  2005-08-01       Impact factor: 6.466

8.  Tyrosine kinase - Role and significance in Cancer.

Authors:  Manash K Paul; Anup K Mukhopadhyay
Journal:  Int J Med Sci       Date:  2004-06-01       Impact factor: 3.738

9.  Src kinase inhibition promotes the chondrocyte phenotype.

Authors:  Laura Bursell; Anita Woods; Claudine G James; Daphne Pala; Andrew Leask; Frank Beier
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Molecular signatures of cell cycle transcripts in the pathogenesis of Glial tumors.

Authors:  Anitha A Pillai; Rabindra Narayan Bhattacharya; Vishnampet V Radhakrishnan; Moinak Banerjee
Journal:  J Carcinog       Date:  2004-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.